Link: https://ir.athenex.com/news-releases/news-release-details/athenex-announces-initiation-phase-i-clinical-study-china-kx2 BUFFALO, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commer...
see details >>Date: 26-June-2019 Source: MASTVNET (https://www.imastv.com/news/Macao/2019-06-12/334564.html) Subject:Xiangxue & UM – To Build International Innovation Platform and Demonstration Base of Industrialization For TCM Cooperating with University of Macau, Xiang...
see details >>Date: 26-June-2019 The list of Top 100 Pharma Companies in China – 2018 was issued by MENET, including Xiangxue on it. The main selection factors are R&D investment and end-market demands that relates to the choices of clinicians and patients. 由米内网发布了“2018年度中国医药工业百...
see details >>Date: 19-June-2019 The local government of Huazhou and Baoding Hua Juhong Industry Co., Ltd., a subsidiary of Guangzhou Xiangxue Pharmaceutical Co., Ltd., held the foundation ceremony of Provincial Agricultural Industrial Park of Hua Juhong (Exocarpium Citrus Grandis). The construction of indus...
see details >>
No. 2, Jinfengyuan Road, Science City,
Guangzhou Economic and Technological Development Zone
020-22211555